Despite Twist Bioscience's unprofitability, rapid revenue growth indicates positive prospects. However, persistent share price decline hints at capital raising issues. Investors should assess the firm's balance sheet, market conditions and specific risks.
Twist Bioscience股票讨论
出售 🔴\\ $Zoom视频通讯 (ZM.US)$ $天宝导航公司 (TRMB.US)$ $Twist Bioscience (TWST.US)$ $UiPath (PATH.US)$
• 编辑基因 | $CRISPR Therapeutics (CRSP.US)$ , $Intellia Therapeutics (NTLA.US)$ , $Beam Therapeutics (BEAM.US)$ , $Verve Therapeutics (VERV.US)$ , $Editas Medicine (EDIT.US)$
• 创建疗法 | $Prime Medicine (PRME.US)$ , $Sana Biotechnology (SANA.US)$
• 构建 DNA | $Twist Bioscience (TWST.US)$ , $Ginkgo Bioworks (DNA.US)$ , $Pacific Biosciences of California (PACB.US)$ , $Illumina (ILMN.US)$
• 磁盘...
暂无评论